跳至主要内容
临床试验/NL-OMON52326
NL-OMON52326招募中不适用

Glucose transport and mitochondrial function in type 1 diabetes mellitus - GRACE

Vrije Universiteit0 个研究点目标入组 41 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
41

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • In order to be eligible to participate in this study, participants with T1DM
  • must meet all of the following criteria:
  • Individuals with T1DM with a diagnosed disease duration of 1 - 45 years
  • Male or female
  • Aged between 18-65 years
  • In order to be eligible to participate in this study, healthy control
  • participants must meet all of the following criteria:
  • No chronic health conditions and between the ages of 18-65

排除标准

  • History of asthma, stroke, chronic obstructive pulmonary disease, congestive
  • heart failure, heart surgery, or congenital heart diseases
  • Current treatment with drugs known to interfere with metabolism e.g. systemic
  • corticosteroids, statins, SGLT2 inhibitors, GLP1 receptor agonists
  • Are current smokers or have been a regular smoker within the last 12 months
  • Insulin pump therapy
  • Symptomatic autonomic or distal neuropathy
  • BMI >30 due to adiposity, since this is known to cause difficulties in
  • obtaining muscle biopsies.
  • Pregnancy
  • Recent acute myocardial infarction (<6 months)
  • Uncontrolled arrhythmia/severe conduction disorder (atrial fibrillation or
  • second/third degree AV block) causing hemodynamic compromise
  • Implantable pacemaker or other cardiac device with complete ventricular pacing
  • Uncontrolled heart failure with hemodynamic compromise
  • Uncontrolled hypertension (Systolic Blood Pressure >150 mmHg and Diastolic
  • Blood Pressure > 100 mmHg on repeated measurements)
  • Active infection, anaemia, severe renal dysfunction (estimated Glomerular
  • filtration rate <30 ml/min/1,73m2) likely to significantly impact on exercise
  • performance
  • Chronic illness (including orthopaedic, endocrinological, haematological,
  • malignant, gastrointestinal, neurological, muscle or inflammatory disorders)
  • likely to significantly impact on exercise performance
  • > 6 alcohol units per day or >14 alcohol units per week
  • Use of anticoagulants or anti platelet therapy

研究者

相似试验